Pharmacological treatment approaches for eating disorders, such as binge eating disorder and bulimia nervosa, are currently limited.
Methods and aims:
Using a well-characterized animal model of binge eating, we investigated the epigenetic regulation of the A2A Adenosine Receptor (A2AAR) and dopaminergic D2 receptor (D2R) genes.
Results:
Gene expression analysis revealed a selective increase of both receptor mRNAs in the amygdaloid complex of stressed and restricted rats, which exhibited binge-like eating, when compared to non-stressed and non-restricted rats. Consistently, pyrosequencing analysis revealed a significant reduction of the percentage of DNA methylation but only at the A2AAR promoter region in rats showing binge-like behaviour compared to the control animals. Focusing thus on A2AAR agonist (VT 7) administration (which inhibited the episode of binge systemically at 0.1 mg/kg or intra-central amygdala (CeA) injection at 900 ng/side) induced a significant increase of A2AAR mRNA levels in restricted and stressed rats when compared to the control group. In addition, we observed a significant decrease in A2AAR mRNA levels in rats treated with the A2AAR antagonist (ANR 94) at 1 mg/kg. Consistent changes in the DNA methylation status of the A2AAR promoter were found in restricted and stressed rats after administration of VT 7 or ANR 94.
Conclusion:
We confirm the role of A2AAR in binge eating behaviours, and we underline the importance of epigenetic regulation of the A2AAR gene, possibly due to a compensatory mechanism to counteract the effect of binge eating. We suggest that A2AAR activation, inducing receptor gene up-regulation, could be relevant to reduction of food consumption.
AlboniSMicioni Di BonaventuraMVBenattiC, et al. (2017) Hypothalamic expression of inflammatory mediators in an animal model of binge eating. Behav Brain Res320: 420–430.
2.
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). Arlington, VA: American Psychiatric Publishing.
3.
AvenaNMBocarslyME (2012) Dysregulation of brain reward systems in eating disorders: Neurochemical information from animal models of binge eating, bulimia nervosa, and anorexia nervosa. Neuropharmacology63: 87–96.
4.
AvenaNMBocarslyMERadaP, et al. (2008) After daily bingeing on a sucrose solution, food deprivation induces anxiety and accumbens dopamine/acetylcholine imbalance. Physiol Behav94: 309–315.
BlasioAIemoloASabinoV, et al. (2013) Rimonabant precipitates anxiety in rats withdrawn from palatable food: Role of the central amygdala. Neuropsychopharmacology38: 2498–2507.
7.
BroftAIBernerLAMartinezD, et al. (2011) Bulimia nervosa and evidence for striatal dopamine dysregulation: a conceptual review. Physiol Behav104: 122–127.
8.
BuiraSPAlbasanzJLDentesanoG, et al. (2010) DNA methylation regulates adenosine A(2A) receptor cell surface expression levels. J Neurochem112: 1273–1285.
9.
ChomczynskiPSacchiN (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem162: 156–159.
10.
CifaniCDi BonaventuraMVMCiccocioppoR, et al. (2013) Binge eating in female rats induced by Yo-Yo dieting and stress. In: AvenaNM (ed.) Animal Models of Eating Disorders. New York, NY: Springer, pp. 27–49.
11.
CifaniCKoyaENavarreBM, et al. (2012) Medial prefrontal cortex neuronal activation and synaptic alterations after stress-induced reinstatement of palatable food seeking: A study using c-fos-GFP transgenic female rats. J Neurosci32: 8480–8490.
12.
CifaniCMicioni DiBMVitaleG, et al. (2010) Effect of salidroside, active principle of Rhodiola rosea extract, on binge eating. Physiol Behav101: 555–562.
13.
CifaniCPolidoriCMelottoS, et al. (2009) A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: Effect of sibutramine, fluoxetine, topiramate, and midazolam. Psychopharmacology (Berl)204: 113–125.
14.
D’AddarioCMicioni Di BonaventuraMVPucciM, et al. (2014) Endocannabinoid signaling and food addiction. Neurosci Biobehav Rev47: 203–224.
15.
DammannGTeschlerSHaagT, et al. (2011) Increased DNA methylation of neuropsychiatric genes occurs in borderline personality disorder. Epigenetics6: 1454–1462.
16.
DingemansAEvan FurthEF (2012) Binge eating disorder psychopathology in normal weight and obese individuals. Int J Eat Disord45: 135–138.
17.
FenuSPinnaAOnginiE, et al. (1997) Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats. Eur J Pharmacol321: 143–147.
18.
FerreSQuirozCWoodsAS, et al. (2008) An update on adenosine A2A-dopamine D2 receptor interactions: Implications for the function of G protein-coupled receptors. Curr Pharm Des14: 1468–1474.
19.
FinkJSWeaverDRRivkeesSA, et al. (1992) Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. Brain Res Mol Brain Res14: 186–195.
20.
GasiorMHudsonJQuinteroJ, et al. (2017) A phase 3, multicenter, open-label, 12-month extension safety and tolerability trial of lisdexamfetamine dimesylate in adults with binge eating disorder. J Clin Psychopharmacol37: 315–322.
21.
GroleauPJooberRIsraelM, et al. (2014) Methylation of the dopamine D2 receptor (DRD2) gene promoter in women with a bulimia-spectrum disorder: Associations with borderline personality disorder and exposure to childhood abuse. J Psychiatr Res48: 121–127.
22.
HaasJFreseKSParkYJ, et al. (2013) Alterations in cardiac DNA methylation in human dilated cardiomyopathy. EMBO Mol Med5: 413–429.
23.
HaskoGPacherP (2008) A2A receptors in inflammation and injury: Lessons learned from transgenic animals. J Leukoc Biol83: 447–455.
24.
HillionJCanalsMTorvinenM, et al. (2002) Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J Biol Chem277: 18091–18097.
25.
HudsonJIMcElroySLFerreira-CornwellMC, et al. (2017) Efficacy of lisdexamfetamine in adults with moderate to severe binge-eating disorder: a randomized controlled clinical trial. JAMA Psychiatry74: 903–910.
26.
IemoloABlasioASt CyrSA, et al. (2013) CRF-CRF1 receptor system in the central and basolateral nuclei of the amygdala differentially mediates excessive eating of palatable food. Neuropsychopharmacology38: 2456–2466.
27.
JavarasKNPopeHGLalondeJK, et al. (2008) Co-occurrence of binge eating disorder with psychiatric and medical disorders. J Clin Psychiatry69: 266–273.
28.
JohnsonPMKennyPJ (2010) Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci13: 635–641.
29.
KrethSLedderoseCKaufmannI, et al. (2008) Differential expression of 5’-UTR splice variants of the adenosine A2A receptor gene in human granulocytes: identification, characterization, and functional impact on activation. FASEB J22: 3276–3286.
30.
KrugelUKittnerHFrankeH, et al. (2003) Purinergic modulation of neuronal activity in the mesolimbic dopaminergic system in vivo. Synapse47: 134–142.
31.
LeeYCChienCLSunCN, et al. (2003) Characterization of the rat A2A adenosine receptor gene: a 4.8-kb promoter-proximal DNA fragment confers selective expression in the central nervous system. Eur J Neurosci18: 1786–1796.
32.
LiCCCropleyJECowleyMJ, et al. (2011) A sustained dietary change increases epigenetic variation in isogenic mice. PLoS Genet7: e1001380.
33.
Lopez-CruzLCarbo-GasMPardoM, et al. (2017) Adenosine A2A receptor deletion affects social behaviors and anxiety in mice: Involvement of anterior cingulate cortex and amygdala. Behav Brain Res321: 8–17.
34.
MacCollinMPeterfreundRMacDonaldM, et al. (1994) Mapping of a human A2a adenosine receptor (ADORA2) to chromosome 22. Genomics20: 332–333.
35.
MauroVPEdelmanGM (2002) The ribosome filter hypothesis. Proc Natl Acad Sci U S A99: 12031–12036.
36.
McElroySLHudsonJFerreira-CornwellMC, et al. (2016a) Lisdexamfetamine dimesylate for adults with moderate to severe binge eating disorder: Results of two pivotal phase 3 randomized controlled trials. Neuropsychopharmacology41: 1251–60.
37.
McElroySLHudsonJIGasiorM, et al. (2017) Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge eating disorder. Int J Eat Disord50: 884–92.
38.
McElroySLHudsonJIMitchellJE, et al. (2015) Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge eating disorder: A randomized clinical trial. JAMA Psychiatry72: 235–246.
39.
McElroySLMitchellJEWilfleyD, et al. (2016b) Lisdexamfetamine dimesylate effects on binge eating behaviour and obsessive compulsive and impulsive features in adults with binge eating disorder. Eur Eat Disord Rev24: 223–231.
40.
Micioni Di BonaventuraMVCiccocioppoRRomanoA, et al. (2014) Role of bed nucleus of the stria terminalis corticotrophin-releasing factor receptors in frustration stress-induced binge-like palatable food consumption in female rats with a history of food restriction. J Neurosci34: 11316–11324.
41.
Micioni Di BonaventuraMVCifaniCLambertucciC, et al. (2012a) Effects of A(2)A adenosine receptor blockade or stimulation on alcohol intake in alcohol-preferring rats. Psychopharmacology (Berl)219: 945–957.
42.
Micioni Di BonaventuraMVCifaniCLambertucciC, et al. (2012b) A2A adenosine receptor agonists reduce both high-palatability and low-palatability food intake in female rats. Behav Pharmacol23: 567–574.
43.
Micioni Di BonaventuraMVLutzTARomanoA, et al. (2017a) Estrogenic suppression of binge-like eating elicited by cyclic food restriction and frustrative-nonreward stress in female rats. Int J Eat Disord50: 624–635.
44.
Micioni Di BonaventuraMVUbaldiMGiusepponiME, et al. (2017b) Hypothalamic CRF1 receptor mechanisms are not sufficient to account for binge-like palatable food consumption in female rats. Int J Eat Disord50: 1194–1204.
45.
Micioni Di BonaventuraMVUbaldiMLiberatiS, et al. (2013) Caloric restriction increases the sensitivity to the hyperphagic effect of nociceptin/orphanin FQ limiting its ability to reduce binge eating in female rats. Psychopharmacology (Berl)228: 53–63.
46.
Micioni Di BonaventuraMVVitaleGMassiM, et al. (2012c) Effect of hypericum perforatum extract in an experimental model of binge eating in female rats. J Obes2012: 956137.
47.
MingoteSPereiraMFarrarAM, et al. (2008) Systemic administration of the adenosine A(2A) agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intake. Pharmacol Biochem Behav89: 345–351.
48.
MonteleonePMajM (2008) Genetic susceptibility to eating disorders: Associated polymorphisms and pharmacogenetic suggestions. Pharmacogenomics9: 1487–1520.
49.
NairSGNavarreBMCifaniC, et al. (2011) Role of dorsal medial prefrontal cortex dopamine D1-family receptors in relapse to high-fat food seeking induced by the anxiogenic drug yohimbine. Neuropsychopharmacology36: 497–510.
50.
NunesEJRandallPAPodurgielS, et al. (2013) Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: Effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors. Neurosci Biobehav Rev37: 2015–2025.
51.
PankevichDETeegardenSLHedinAD, et al. (2010) Caloric restriction experience reprograms stress and orexigenic pathways and promotes binge eating. J Neurosci30: 16399–16407.
52.
PardoMLopez-CruzLValverdeO, et al. (2012) Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice. Neuropharmacology62: 2068–2077.
53.
PaxinosGWatsonC (2005) The Rat Brain in Stereotaxic Coordinates. San Diego: Elsevier Academic Press.
54.
PiccoliLMicioni Di BonaventuraMVCifaniC, et al. (2012) Role of orexin-1 receptor mechanisms on compulsive food consumption in a model of binge eating in female rats. Neuropsychopharmacology37: 1999–2011.
55.
PjetriEDempsterECollierDA, et al. (2013) Quantitative promoter DNA methylation analysis of four candidate genes in anorexia nervosa: A pilot study. J Psychiatr Res47: 280–282.
56.
PritchettCEPardeeALMcGuirkSR, et al. (2010) The role of nucleus accumbens adenosine-opioid interaction in mediating palatable food intake. Brain Res1306: 85–92.
57.
PucciMMicioni Di BonaventuraMVGiusepponiME, et al. (2016) Epigenetic regulation of nociceptin/orphanin FQ and corticotropin-releasing factor system genes in frustration stress-induced binge-like palatable food consumption. Addict Biol21: 1168–1185.
58.
PucciMMicioni Di BonaventuraMVZaplaticE, et al. (2019) Transcriptional regulation of the endocannabinoid system in a rat model of binge-eating behavior reveals a selective modulation of the hypothalamic fatty acid amide hydrolase gene. Int J Eat Disord52: 51–60.
59.
RauARAriwodolaOJWeinerJL (2015) Postsynaptic adenosine A2A receptors modulate intrinsic excitability of pyramidal cells in the rat basolateral amygdala. Int J Neuropsychopharmacol18: pyv017.
60.
RosinDLRobevaAWoodardRL, et al. (1998) Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system. J Comp Neurol401: 163–186.
61.
RuddockHKChristiansenPHalfordJCG, et al. (2017) The development and validation of the addiction-like eating behaviour scale. Int J Obes (Lond)41: 1710–1717.
62.
SalamoneJDCorreaMNunesEJ, et al. (2012) The behavioral pharmacology of effort-related choice behavior: Dopamine, adenosine and beyond. J Exp Anal Behav97: 125–146.
63.
SalamoneJDFarrarAMFontL, et al. (2009) Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism. Behav Brain Res201: 216–222.
64.
SimoesAPMachadoNJGoncalvesN, et al. (2016) Adenosine A2A receptors in the amygdala control synaptic plasticity and contextual fear memory. Neuropsychopharmacology41: 2862–2871.
65.
Villar-MenendezIBlanchMTyebjiS, et al. (2013) Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington’s disease. Neuromolecular Med15: 295–309.
66.
Villar-MenendezIDiaz-SanchezSBlanchM, et al. (2014) Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia. J Psychiatr Res51: 49–59.
67.
VolpiniRCostanziSLambertucciC, et al. (2004) Adenosine receptor agonists: Synthesis and binding affinity of 2-(aryl) alkylthioadenosine derivatives. ARKIVOC5: 301–311.
68.
VolpiniRDal BenDLambertucciC, et al. (2009) Adenosine A2A receptor antagonists: New 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson’s disease. Chem Med Chem4: 1010–1019.
69.
WangGJGeliebterAVolkowND, et al. (2011) Enhanced striatal dopamine release during food stimulation in binge eating disorder. Obesity (Silver Spring)19: 1601–1608.
70.
WolffGECrosbyRDRobertsJA, et al. (2000) Differences in daily stress, mood, coping, and eating behavior in binge eating and nonbinge eating college women. Addict Behav25: 205–216.
71.
YuLFrithMCSuzukiY, et al. (2004) Characterization of genomic organization of the adenosine A2A receptor gene by molecular and bioinformatics analyses. Brain Res1000: 156–173.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
